Group One Trading’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-16,406
| Closed | -$2.48M | – | 8396 |
|
|
2025
Q2 | $2.29M | Buy |
+16,406
| New | +$2.3M | 0.01% | 1999 |
|
|
2025
Q1 | – | Sell |
-16,379
| Closed | -$2.37M | – | 7571 |
|
|
2024
Q4 | $2.15M | Buy |
+16,379
| New | +$2.29M | ﹤0.01% | 1851 |
|
|
2024
Q2 | – | Sell |
-681
| Closed | -$102K | – | 6708 |
|
|
2024
Q1 | $92.2K | Buy |
+681
| New | +$90.2K | ﹤0.01% | 4223 |
|
|
2021
Q2 | – | Sell |
-39,704
| Closed | -$4.36M | – | 8126 |
|
|
2021
Q1 | $3.95M | Sell |
39,704
-17,346
| -30% | -$1.74M | 0.01% | 1768 |
|
|
2020
Q4 | $5.7M | Buy |
57,050
+38,361
| +205% | +$4.06M | 0.01% | 1177 |
|
|
2020
Q3 | $2.05M | Buy |
+18,689
| New | +$2.08M | 0.01% | 1574 |
|
|
2019
Q2 | – | Sell |
-6,713
| Closed | -$526K | – | 4938 |
|
|
2019
Q1 | $543K | Buy |
+6,713
| New | +$529K | 0.01% | 1880 |
|
|
2018
Q1 | – | Sell |
-13,292
| Closed | -$921K | – | 4816 |
|
|
2017
Q4 | $922K | Buy |
+13,292
| New | +$896K | 0.01% | 1772 |
|
|
2017
Q3 | – | Sell |
-33,910
| Closed | -$2.14M | – | 4806 |
|
|
2017
Q2 | $2.31M | Sell |
33,910
-106,330
| -76% | -$6.94M | 0.02% | 868 |
|
|
2017
Q1 | $8.73M | Buy |
140,240
+48,601
| +53% | +$2.83M | 0.1% | 227 |
|
|
2016
Q4 | $5.01M | Buy |
91,639
+89,638
| +4,480% | +$5.09M | 0.05% | 449 |
|
|
2016
Q3 | $132K | Sell |
2,001
-1,082
| -35% | -$70.7K | ﹤0.01% | 2761 |
|
|
2016
Q2 | $186K | Sell |
3,083
-2,864
| -48% | -$166K | ﹤0.01% | 2449 |
|
|
2016
Q1 | $335K | Buy |
5,947
+1,006
| +20% | +$60.4K | ﹤0.01% | 1979 |
|
|
2015
Q4 | $335K | Sell |
4,941
-19,555
| -80% | -$1.28M | ﹤0.01% | 2122 |
|
|
2015
Q3 | $1.56M | Sell |
24,496
-14,722
| -38% | -$969K | 0.02% | 947 |
|
|
2015
Q2 | $2.5M | Buy |
39,218
+23,791
| +154% | +$1.63M | 0.04% | 617 |
|
|
2015
Q1 | $1.06M | Sell |
15,427
-169,916
| -92% | -$11.8M | 0.02% | 1036 |
|
|
2014
Q4 | $13M | Sell |
185,343
-163,103
| -47% | -$11.7M | 0.2% | 87 |
|
|
2014
Q3 | $24.9M | Buy |
348,446
+246,002
| +240% | +$18M | 0.38% | 28 |
|
|
2014
Q2 | $7.61M | Buy |
+102,444
| New | +$7.41M | 0.12% | 175 |
|
Other funds holding AZN
EP
IA
Group One Trading's AZN Position: Q3 2025 in Review
Group One Trading sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 16,406 shares — an estimated $2.48M sold.
Group One Trading first reported a position in AZN in Q2 2014 and held it in 21 quarters. The position peaked at $24.9M in Q3 2014. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.
- Group One Trading reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 16,406 AstraZeneca shares in Q3 2025, an estimated $2.48M.
- Group One Trading first reported a position in AstraZeneca in Q2 2014 and held it in 21 quarters.
- Group One Trading's AstraZeneca position peaked at $24.9M in Q3 2014.
- 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.